[Undesirable metabolic effects following the administration of larger doses of fructose and sorbitol].
D000208:Acute Disease; D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control; D004347:Drug Interactions; D004734:Energy Metabolism; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005688:Galactosamine / Q000009:adverse effects; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D010288:Parenteral Nutrition / Q000009:adverse effects*; D051381:Rats; D013012:Sorbitol / Q000008:administration & dosage / Q000009:adverse effects*; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D005632:Fructose; D013012:Sorbitol; D005688:Galactosamine; D000255:Adenosine Triphosphate
Unerwünschte Stoffwechselwirkungen bei Gabe höherer Dosen von Fruktose und Sorbit